CEO & Co-founder
Guillaume Wegria is a bioengineer with a Master’s degree in management. Before co-founding Fyteko in 2014, he worked for 10 years at Materia Nova, an R&D-focused biotech, leading the team through the successful completion of several European projects. In 2016, following the launch of Fyteko, Guillaume was named by the MIT Technology Review as one of its “Innovators under 35”, a global list of innovators, pioneers and changemakers. Guillaume has held the roles of CEO and Board Chairman since launch, handling day-to-day management, investor relations, all European projects and the company’s global vision.